HK Stock MarketDetailed Quotes

00867 CMS

Watchlist
  • 6.690
  • +0.150+2.29%
Noon Break Jul 22 11:45 CST
16.32BMarket Cap6.16P/E (TTM)

About CMS Company

CMS is an open platform enterprise that links pharmaceutical innovation and commercialization, controls product life cycle management, and is committed to providing competitive products and services to meet unmet medical needs. Kang Zhe Pharmaceutical Co., Ltd. focuses on the innovative products of the global initiative (FIC) and the best of its kind (BIC). It has a rich innovation pipeline with differentiated layout, high innovation level and great market potential. Kangzhe Pharmaceutical Co., Ltd. focuses on the specialist field, has proven commercialization capabilities, extensive channel network and expert resources, and the core products on sale have gained a leading academic and market position. Focus on the in-depth development of superior specialist areas, expand the boundary, in order to consolidate the competitiveness of cardio-cerebrovascular / digestive business, and operate the skin and ophthalmology business independently to improve scale efficiency. At the same time, the business territory is expanded to the Southeast Asian market, making great efforts to become the "bridgehead" for global pharmaceutical companies to enter the Southeast Asian market, and to promote the high-quality, sustained and healthy development of Kangzhe Pharmaceutical Industry.

Company Profile

Symbol00867
Company NameCMS
ISINKYG211081248
Listing DateSep 28, 2010
Issue Price5.06
Shares Offered200.00M share(s)
FoundedDec 18, 2006
Registered AddressCayman Islands
Chairmangang lin
Secretarysanyan wu
Audit InstitutionDeloitte - Guan Huang Chen Fang Certified Public Accountants
Company CategoryOther
Registered OfficePO Box 309 Ugland House Grand Cayman, KY1-1104 Cayman Islands
Head Office and Principal Place of BusinessRoom 2106, 21st floor, Port Transport Tower, 510 King's Road, North Point, Hong Kong
Fiscal Year Ends12-31
Employees5701
MarketHong Kong motherboard
Phone(86)75582416868
Fax(852)23891320
Emailinfo@cms.net.cn
Business Kangzhe Pharmaceutical is an open platform enterprise that links pharmaceutical innovation and commercialization and controls the management of the entire product life cycle. It is committed to providing competitive products and services to meet unmet medical needs. Kangzhe Pharmaceutical focuses on the world's first (FIC) and best-in-class (BIC) innovative products, and has laid out a rich innovation pipeline with differentiated, high innovation levels, and great market potential. Kangzhe Pharmaceutical focuses on specialized fields, has proven commercialization capabilities, extensive channel networks and expert resources, and its core products have won leading academic and market positions. Continuously develop and expand boundaries around superior specialty fields to consolidate the competitiveness of the cardiovascular and cerebrovascular/digestive business, and operate the skin and ophthalmology business independently to improve scale efficiency. At the same time, the business map has expanded to the Southeast Asian market, focusing on becoming a “bridgehead” for global pharmaceutical companies to enter the Southeast Asian market, helping Kangzhe Pharmaceutical to develop in a high-quality, sustainable and healthy manner.

Company Executives

  • Name
  • Position
  • Salary
  • gang lin
  • Presidencies, CEOs, President, CEO, Executive Director, Nomination Committee Members, Authorized Representative
  • 5.44M
  • hongbing chen
  • VP, Executive Director, Chief Operating Officer
  • 5.04M
  • yanling chen
  • VP, Executive Director, Chief Financial Officer
  • 4.43M
  • chuangshun liang
  • Independent Non-Executive Director, Remuneration Committee Chairman, Audit Committee Members, Nomination Committee Members
  • 323.00K
  • ying luo
  • Independent Non-Executive Director, Chairman of the Nomination Committee, Remuneration Committee Members, Audit Committee Members
  • 323.00K
  • zheng feng
  • Independent Non-Executive Director, Chairman of the Audit Committee, Remuneration Committee Members, Nomination Committee Members
  • 323.00K
  • huaizheng peng
  • Chief Commercial Officer of the Group
  • --
  • James Stearns
  • The Group's Chief Investment Officer (Europe and America)
  • --
  • fei jiang
  • The Group's Chief Investment Officer (Greater China)
  • --
  • qingfu jiang
  • General Manager of the Group's Cardiovascular and Digestive Business (Shenzhen Kangzhe)
  • --
  • anjun huang
  • General Manager of the Group's Dermatology and Aesthetic Business (Kang Zhe Beauty)
  • --
  • linlang wang
  • General Manager of the Group's Ophthalmology Business (Kang Zhewei Sheng)
  • --
  • lieyi ma
  • General Manager of the Group's Business Operation Center
  • --
  • yufang li
  • General Manager of the Group's Financial Center
  • --
  • sanyan wu
  • Director of Legal Affairs, Authorized Representative, Company Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg